HPV 16,18,31,33,35,39,45,51,52,56,58,59 (DNA, screen test)

We remind you that independent interpretation of the results is unacceptable; the information below is for reference only.

Human papillomavirus (HPV) is a group of viruses that can cause various diseases, including cervical cancer, vulvar cancer, vaginal cancer, anal canal cancer, penile cancer, and some types of head and neck cancers. There are more than 200 types of HPV, some of which are considered oncogenic or highly oncogenic and are associated with the development of cancer.

Oncogenic types of HPV:
HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 are considered oncogenic or highly oncogenic. These HPV types can cause precancerous changes in cells, which over time may lead to the development of cancer. However, the presence of these types of HPV does not automatically mean that cancer will develop, as other factors also influence this process.

Vaccination and prevention:
Vaccination against HPV is considered an effective measure to prevent HPV‑associated cancers and is recommended for preadolescent girls and boys. In addition, it is important to follow your doctor’s recommendations for periodic screenings and to adopt precautionary measures to reduce the risk of HPV transmission.

Role of screening
Screening for high‑risk human papillomavirus (HPV) plays an important role in diagnosing and preventing cervical cancer and other HPV‑associated cancers. Detecting these HPV strains allows doctors to identify the risk of developing precancerous conditions in a timely manner and take necessary measures for treatment and monitoring.

Indications
• Cervical cancer screening: Regular screening for high‑risk HPV is recommended for women between certain ages (often 21–65) to identify precancerous changes and detect cervical cancer early.
• Monitoring after treatment of precancerous conditions: To monitor the effectiveness of treatment for precancerous cervical conditions and to detect recurrences.
• Other HPV‑associated cancers: HPV screening may be recommended when there is suspicion of other HPV‑associated cancers, such as vulvar, vaginal, anal, or oropharyngeal cancers.

Procedure
For this analysis, it is necessary to collect a biological sample (a cervical swab or scraping from the cervix). The procedure is performed by a medical professional and takes a few minutes. After sample collection, minor discomfort may occur, which usually resolves on its own.


Sources

https://www.cdc.gov/std/treatment-guidelines/hpv-cancer.htm
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812266/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373819/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077029/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561418/

IMPORTANT!

It is crucial to remember that the information provided in this section is not intended for self-diagnosis or treatment. If you experience pain or an exacerbation of a medical condition, it is essential to consult a doctor for diagnostic testing and appropriate treatment. Only a qualified specialist can make an accurate diagnosis and determine the appropriate treatment. To ensure the most accurate and consistent evaluation of test results, it is recommended to have them performed at the same laboratory. This is because different laboratories may use various methods and units of measurement for similar tests.